Concerning the underlying molecular mechanisms leading to PRELP downregulation, genomic abnormalities in PRELP, such as mutations and deletions, were only found at a low frequency (7%) suggesting deregulation as a major mechanism of impaired PRELP expression in melanoma (Additional file 1: Fig. S3). The gene discussed is PRELP; the disease is melanoma.